期刊
CANCER RESEARCH
卷 78, 期 21, 页码 6048-6058出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-18-1029
关键词
-
类别
资金
- Gobierno de Navarra [0011-1408-2016-000004]
- European Commission SME H2020 [777373]
- Ministerio de Economia y Competitividad [PTQ-14-07320]
- Foundation for Applied Medical Research (FIMA)
- University of Navarra (Pamplona, Spain)
Zebrafish (Danio rerio) is an ideal in vivo model to study a wide variety of human cancer types. In this review, we provide a comprehensive overview of zebrafish in the cancer drug discovery process, from (i) approaches to induce malignant tumors, (ii) techniques to monitor cancer progression, and (iii) strategies for compound administration to (iv) a compilation of the 355 existing case studies showing the impact of zebrafish models on cancer drug discovery, which cover a broad scope of scenarios. Finally, based on the current state-of-the-art analysis, this review presents some highlights about future directions using zebrafish in cancer drug discovery and the potential of this model as a prognostic tool in prospective clinical studies. (C) 2018 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据